5th Latin American and 1st Central American Conference on Drug Policy
The Latin American Conference on Drug Policy is one of the primary spaces for debate on drugs in the region, where government officials, UN agents, experts and individuals from civil society meet every two years to evaluate, reflect and discuss how to give alternative, innovative and concerted responses that allow a comprehensive approach to the problems related to drug crimes and abuse. The Conference is endorsed by the United Nations Development Program (UNDP), the United Nations Office on Drugs and Crime (UNODC), the Pan American Health Organization, World Health Organization (PAHO / WHO), the Joint United Nations Program on AIDS (UNAIDS), the Organization of American States (OAS), and the the United Nations Latin American Institute for Crime Prevention and Treatment (ILANUD). It was declared of Cultural Interest by the Presidency of the Republic of Costa Rica and the Ministry of Culture and Youth of the Republic of Costa Rica.
Institutional design
Formalization: is the innovation embedded in the constitution or legislation, in an administrative act, or not formalized at all?
Frequency: how often does the innovation take place: only once, sporadically, or is it permanent or regular?
Mode of Selection of Participants: is the innovation open to all participants, access is restricted to some kind of condition, or both methods apply?
Type of participants: those who participate are individual citizens, civil society organizations, private stakeholders or a combination of those?
Decisiveness: does the innovation takes binding, non-binding or no decision at all?
Co-governance: is there involvement of the government in the process or not?
- Formalization
- not backed by constitution nor legislation, nor by any governmental policy or program
- Frequency
- single
- Mode of selection of participants
- restricted
- Type of participants
- civil society
- Decisiveness
- democratic innovation yields no decision
- Co-Governance
- yes
Means
|
Ends
|
